236 - Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Glenn S. Tillotson, PhD

CONSULTANT MICROBIOLOGIST
GST Micro LLC
NORTH, Virginia, United States

PF

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine/Attending Gastroenterologist
Yale University School of Medicine/PACT-Gastroenterology Center
Westport, Connecticut, United States
LA

Laurie Archbald-Pannone, MD

University of Virginia
Charlottesville, Virginia, United States
Stuart Johnson, M.D.

ID Physician and Researcher
Hines VA Hospital and Loyola University Medical Center
Hines, Illinois, United States
SN

Samson Ng, PharmD

Ferring Pharmaceuticals
Parsippany, New Jersey, United States
MA

Masakazu Ando, PhD

Ferring Pharmaceuticals
Parsippany, New Jersey, United States
AH

Adam Harvey, PhD

Clinical Scientist
Ferring Pharmaceuticals
Roseville, Minnesota, United States